ada glp 1 guidelines 🔴ADA Standards of Care in Diabetes 2025: ▪️ Cardiovascular risk: Use GLP-1 RA or SGLT2 inhibitors for glycemic control & cardiovascular risk reduction. ▪️ Heart failure: SGLT2 inhibitors recommended for glycemic Figure 8.2 from 8. Pharmacologic

Does Aetna cover Wegovy, Zepbound, and Ozempic in 2026

Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p=0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p=0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p=0.0315)

Weight-loss drugs like Ozempic are in shortage, and telehealth startups are selling compounded versions

Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.

Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity

Learn how to use them, manage side effects and achieve long-term success.